Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ekso Bionics Holdings Inc (EKSO)
Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,352
  • Shares Outstanding, K 14,235
  • Annual Sales, $ 12,910 K
  • Annual Income, $ -15,080 K
  • 60-Month Beta 1.87
  • Price/Sales 1.72
  • Price/Cash Flow N/A
  • Price/Book 1.55
Trade EKSO with:

Options Overview Details

View History
  • Implied Volatility 90.31% ( -141.76%)
  • Historical Volatility 107.57%
  • IV Percentile 9%
  • IV Rank 7.29%
  • IV High 880.76% on 08/17/23
  • IV Low 28.16% on 11/13/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 9
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 239
  • Open Int (30-Day) 215

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.33
  • Number of Estimates 1
  • High Estimate -0.33
  • Low Estimate -0.33
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2100 +23.97%
on 11/10/23
1.7900 -16.20%
on 11/30/23
unch (unch)
since 11/08/23
3-Month
0.6220 +141.16%
on 09/26/23
1.7900 -16.20%
on 11/30/23
+0.8050 (+115.83%)
since 09/08/23
52-Week
0.6200 +141.94%
on 09/08/23
1.8800 -20.21%
on 01/26/23
+0.0300 (+2.04%)
since 12/08/22

Most Recent Stories

More News
Ekso Bionics: Q3 Earnings Snapshot

Ekso Bionics: Q3 Earnings Snapshot

EKSO : 1.5100 (+0.67%)
Ekso Bionics: Q2 Earnings Snapshot

Ekso Bionics: Q2 Earnings Snapshot

EKSO : 1.5100 (+0.67%)
Ekso Bionics: Q1 Earnings Snapshot

Ekso Bionics: Q1 Earnings Snapshot

EKSO : 1.5100 (+0.67%)
Ekso Bionics: Q4 Earnings Snapshot

Ekso Bionics: Q4 Earnings Snapshot

EKSO : 1.5100 (+0.67%)
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.5100 (+0.67%)
SWAV : 174.48 (-0.35%)
Ekso Bionics: Q3 Earnings Snapshot

Ekso Bionics: Q3 Earnings Snapshot

EKSO : 1.5100 (+0.67%)
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates

Integra (IART) delivered earnings and revenue surprises of 19.44% and 1.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

IART : 41.05 (-0.63%)
EKSO : 1.5100 (+0.67%)
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.5100 (+0.67%)
PEN : 222.29 (-0.40%)
Ekso Bionics Reports Second Quarter 2022 Results

RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...

EKSO : 1.5100 (+0.67%)
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...

EKSO : 1.5100 (+0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western...

See More

Key Turning Points

3rd Resistance Point 1.6767
2nd Resistance Point 1.6333
1st Resistance Point 1.5667
Last Price 1.5100
1st Support Level 1.4567
2nd Support Level 1.4133
3rd Support Level 1.3467

See More

52-Week High 1.8800
Last Price 1.5100
Fibonacci 61.8% 1.3987
Fibonacci 50% 1.2500
Fibonacci 38.2% 1.1013
52-Week Low 0.6200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar